- AIMS
Abnormal Involuntary Movements Scale
- AUC
area under the curve
- BMT
best medical treatment
- CGI-I
Clinician Global Impression of Improvement
- COMT
catechol-O-methyltransferase
- CRD
Centre for Reviews and Dissemination
- DBS
deep brain stimulation
- EAG
External Assessment Group
- EQ-5D
EuroQol-5 Dimensions
- ESS
Epworth sleepiness score
- FDS
fluctuations dyskinesia score
- GKC
Global Kinetics Corporation
- HRQoL
health-related quality of life
- H&Y
Hoehn and Yahr
- ICER
incremental cost-effectiveness ratio
- IPD
individual participant data
- LCIG
levodopa–carbidopa intestinal gel
- LED
levodopa equivalent dose
- LEDD
levodopa equivalent daily dose
- MAO-B
monoamine oxidase type B
- MDS-UPDRS
Movement Disorder Society-Unified Parkinson’s Disease Rating Scale
- MOCA
Montreal Cognitive Assessment
- NICE
National Institute for Health and Care Excellence
- NMSQ
non-motor symptom questionnaire
- NMSQuest
non-motor symptom questionnaire
- NPV
negative predictive value
- PDQ-8
Parkinson’s disease questionnaire-8
- PDQ-39
Parkinson’s disease quality of life 39 questions
- PGI-I
Patient Global Impression of Improvement
- PKG
Personal KinetiGraph
- PPI
Patient and public involvement
- PPV
positive predictive value
- PRISMA
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
- PSS
Personal Social Services
- PTB
per cent time in bradykinesia
- PTD
per cent time in dyskinesia
- PTI
proportion of time immobile
- PTT
per cent time tremor
- PwP
people with Parkinson’s disease
- QALY
quality-adjusted life-year
- QUADAS-2
Quality Assessment of Diagnostic Accuracy Studies-2
- QUIP
Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease
- RCT
randomised controlled trial
- SoC
standard of care
- UDysRS
Unified Dyskinesia Rating Scale
- UPDRS
Unified Parkinson’s Disease Rating Scale
- WOQ-9
9-item wearing-off questionnaire
